{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-010593","form_type":"8-K","ticker":"ALEC","cik":"0001653087","company_name":"Alector, Inc.","filed_at":"2023-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.020393+00:00","generated_at":"2026-06-17T10:33:24.619029+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alector cuts workforce by 11% (30 employees) to focus on late-stage immuno-neurology programs","bullets":["Workforce reduction of ~11% (30 employees) effective March 29, 2023.","One-time restructuring charges of ~$2.2M for severance and benefits.","Company reaffirms cash runway through 2025 beyond key clinical milestones.","Plan expected to be completed in first half of 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-010593","json":"https://secwatch.observer/filing/0000950170-23-010593.json","markdown":"https://secwatch.observer/filing/0000950170-23-010593.md","text":"https://secwatch.observer/filing/0000950170-23-010593.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023010593/0000950170-23-010593-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023010593/alec-20230328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T10:33:24.619029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a2cc23e150ac681ad063c9c94f0b50d21a9894d4","claim":"Alector, Inc. announced a restructuring with charges of approximately $2.2 million affecting the organization (approximately 30 employees).","evidence_excerpt":"multiple key clinical milestones for its prioritized late-stage programs. One-time restructuring charges associated with the reduction in force are expected to be approximately $2.2 million, primarily consisting of personnel expenses such as salaries, one-time severance payments, and other benefits. Cash payments related to these expenses will be paid out and the","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023010593/0000950170-23-010593-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $2.2 million"},{"label":"Affected area","value":"the organization"},{"label":"Headcount","value":"approximately 30 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}